1. Home
  2. EYE vs ZYME Comparison

EYE vs ZYME Comparison

Compare EYE & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$15.89

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$26.05

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYE
ZYME
Founded
1990
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
EYE
ZYME
Price
$15.89
$26.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
$31.22
$38.90
AVG Volume (30 Days)
1.9M
648.0K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
202.78
33.33
EPS
0.54
N/A
Revenue
$1,987,488,000.00
$105,965,000.00
Revenue This Year
$5.56
$183.10
Revenue Next Year
$6.58
N/A
P/E Ratio
$32.02
N/A
Revenue Growth
9.00
38.87
52 Week Low
$14.75
$15.79
52 Week High
$30.02
$31.34

Technical Indicators

Market Signals
Indicator
EYE
ZYME
Relative Strength Index (RSI) 41.34 48.74
Support Level $16.17 $22.26
Resistance Level $19.18 $27.33
Average True Range (ATR) 0.75 1.48
MACD 0.06 -0.44
Stochastic Oscillator 41.62 21.65

Price Performance

Historical Comparison
EYE
ZYME

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: